Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Next predicted deadline: Jun 22, 2024 (Letter of inquiry)

Later predicted deadlines: Jul 19, 2024 (Letter of inquiry), Jul 22, 2024 (Full proposal), Aug 19, 2024 (Full proposal), Oct 21, 2024 (Letter of inquiry), Nov 20, 2024 (Letter of inquiry), Nov 21, 2024 (Full proposal), Dec 20, 2024 (Full proposal)

Grant amount: Up to US $700,000

Fields of work: Cardiovascular Diseases & Systems Hematological Systems Respiratory Diseases & Systems Sleep

Applicant type: Government Entity, Indigenous Group, Nonprofit, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates by 5:00 PM local time of applicant organization:

  • November 21, 2022
  • February 21, 2023 
  • July 21, 2023 
  • November 21, 2023 
  • February 21, 2024 
  • July 22, 2024 
  • November 21, 2024

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates by 5:00 PM local time of applicant organization:

  • December 21, 2022
  • April 18, 2023
  • August 18, 2023 
  • December 21, 2023
  • April 18, 2024 
  • August 19, 2024
  • December 20, 2024

This Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify a lead compound series toward development of potential therapeutic agents to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and development of therapeutic agents.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

Find funders like US Dept. of Health & Human Services: National Institutes of Health (NIH)

See funders proven to support nonprofits like yours.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed May 09, 2023 and last updated May 09, 2023